| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer | Interim CFO
1 company
Ragosa Mark is a Chief Financial Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 36,372 | $22.25 | $809,277.00 | -61.3% | +32.3% | +104.8% | |
| Dec 9, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 27,829 | $21.34 | $593,997.43 | -37.7% | -2.2% | +93.0% | |
| Dec 5, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 15,116 | $21.37 | $323,008.80 | -18.0% | +2.0% | +98.6% | |
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 24,248 | $24.79 | $601,107.92 | -55.7% | -1.5% | +3.2% | |
| Jan 3, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 12,000 | $20.00 | $240,000.00 | -43.4% | -6.3% | -0.2% |